KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Accounts Payables (2017 - 2026)

Guardant Health's Accounts Payables history spans 9 years, with the latest figure at $54.4 million for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 41.22% to $54.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $54.4 million, a 41.22% increase, with the full-year FY2025 number at $54.4 million, up 41.22% from a year prior.
  • Accounts Payables hit $54.4 million in Q4 2025 for Guardant Health, up from $20.1 million in the prior quarter.
  • Over the last five years, Accounts Payables for GH hit a ceiling of $205.3 million in Q3 2023 and a floor of $15.5 million in Q3 2024.
  • Historically, Accounts Payables has averaged $69.5 million across 5 years, with a median of $41.7 million in 2022.
  • Biggest five-year swings in Accounts Payables: skyrocketed 1335.44% in 2021 and later tumbled 92.46% in 2024.
  • Tracing GH's Accounts Payables over 5 years: stood at $105.4 million in 2021, then skyrocketed by 66.87% to $175.8 million in 2022, then crashed by 70.57% to $51.7 million in 2023, then dropped by 25.49% to $38.6 million in 2024, then surged by 41.22% to $54.4 million in 2025.
  • Business Quant data shows Accounts Payables for GH at $54.4 million in Q4 2025, $20.1 million in Q3 2025, and $44.8 million in Q2 2025.